6 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 4, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
Follow ziconotide: new trials by email Literature Review of ziconotide trials Research Report on ziconotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy Ziconotide - Chemotherapy Induced Peripheral Neuropathy (CIPN) | Not yet recruiting | Christian Hospital Northeast Northwest | 24 | 2026-05-02 | 2026-03-30 | |
| Ziconotide for Non-cancer Pain by Intrathecal Administration Ziconotide [Prialt] - Pain, Chronic | Recruiting | ESTEVE Pharmaceuticals SAS | 85 | 2024-10-30 | 2025-02-27 | |
| OP2C : Prialt® Observatory in Clinical Practice Ziconotide Injection - Refractory Pain | Recruiting | Institut Cancerologie de l'Ouest | 300 | 2020-07-10 | 2025-08-17 | |
| Ziconotide as First-Line IDT Ziconotide 100 MCG(microgram)/ML Intrathecal Solution, Quantitative sensory testing, Serum markers: Interleukin-1, Interleukin-6, and tumor necrosis factor - Neuropathic Pain | Phase 4 | Completed | Albany Medical College | 13 | 2016-11-03 | 2021-01-12 |
| Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy Ziconotide, placebo - Painful Myelopathy, Painful Neuropathy | Phase 4 | Withdrawn | Aaron Boster | 2014-01-01 | 2018-09-18 | |
| Patient Registry of Intrathecal Ziconotide Management(PRIZM) Ziconotide - Patients With Severe Chronic Pain | Completed | Jazz Pharmaceuticals | 93 | 2013-07-01 | 2017-03-16 | |
| Intrathecal Bolus Doses of Ziconotide Ziconotide - Peripheral Neuropathy | Phase 4 | Completed | University Hospital, Linkoeping | 26 | 2011-08-01 | 2014-12-30 |
| Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer ziconotide - Pain, Neuropathic Pain | Phase 2 | Unknown | National Cancer Institute, Naples | 16 | 2009-09-01 | 2023-03-24 |
| Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain Ziconotide - Pain | Phase 3 | Completed | Elan Pharmaceuticals | 300 | 2004-02-01 | 2015-12-14 |
| Prialt (Ziconotide) In Severe Chronic Pain Prialt (ziconotide) - Pain | Phase 3 | Completed | Elan Pharmaceuticals | 220 | 2002-08-01 | 2015-12-14 |
| A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain Ziconotide - HIV Infections, Cancer | Phase 2 | Completed | Neurex | 100 | 2005-06-24 |
Pain (4) · Neuralgia (3) · Chronic Pain (2) · Neoplasms (2) · Pain, Intractable (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Bronchiolitis Obliterans Syndrome (1) · HIV Infections (1) · Lymphoma, Follicular (1) · Neuropathy, Painful (1) · Peripheral Nervous System Diseases (1) · Wounds and Injuries (1)
Elan Pharmaceuticals (2) · Aaron Boster (1) · Albany Medical College (1) · Christian Hospital Northeast Northwest (1) · ESTEVE Pharmaceuticals SAS (1) · Institut Cancerologie de l'Ouest (1) · Jazz Pharmaceuticals (1) · National Cancer Institute, Naples (1) · Neurex (1) · University Hospital, Linkoeping (1)
United States (7) · France (2) · Germany (1) · Italy (1) · Spain (1) · Sweden (1)
Aaron L Boster, MD (1) · Alessandro Morabito, M.D. (1) · Arturo Cuomo, M.D. (1) · Christopher L Beuer, MD (1) · Gennaro Russo, M.D. (1) · I-Zu Huang, MD (1)